Springer

SHERPA: Unknown

People

  1. D'Angelica
    D'Angelica
  2. Jarnagin
    Jarnagin
  3. Kingham
    Kingham
  4. Balachandran
    Balachandran
  5. Gonen
    Gonen
  6. Drebin
    Drebin
  7. Wei
    Wei
  8. Soares
    Soares
  9. Chou
    Chou
  10. Kemeny
    Kemeny

Groups

  1. Human Oncology and Pathogenesis Program (166)
  2. GSK Faculty (160)
  3. Surgery (118)
  4. Center for Pancreatic Cancer Research (98)
  5. Department of Medicine (97)
  6. Epidemiology and Biostatistics (90)
  7. Sloan Kettering Institute Postdocs (84)
  8. Population Sciences Research Program (83)
  9. Biostatistics Service (77)
  10. Solid Tumor Oncology Division (74)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (87)
  2. Meeting Abstract (50)
  3. Miscellaneous (10)
  4. Book Section (8)
  5. Review (6)
  6. Editorial (2)
  7. Research Letter (2)
  8. Book Whole (1)
Groups
  1. Human Oncology and Pathogenesis Program (166)
  2. GSK Faculty (160)
  3. Surgery (118)
  4. Center for Pancreatic Cancer Research (98)
  5. Department of Medicine (97)
  6. Epidemiology and Biostatistics (90)

More Groups

People
  1. Vinod Balachandran (84)
  2. Michael D'Angelica (79)
  3. William Jarnagin (78)
  4. T Peter Kingham (77)
  5. Mithat Gonen (59)
  6. Jeffrey Drebin (56)

More People

Years
  1. 2025 (9)
  2. 2024 (24)
  3. 2023 (16)
  4. 2022 (16)
  5. 2021 (14)
  6. 2020 (12)

More Years

Publications
  1. Annals of Surgical Oncology (87)
  2. European Journal of Nuclear Medicine and Molecular Imaging (7)
  3. Acta Neuropathologica (6)
  4. Abdominal Radiology (5)
  5. Breast Cancer Research and Treatment (5)
  6. Journal of Gastrointestinal Surgery (4)

More Publications

Results (166)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Solit, D. B.; Su, Y. B.; Rosen, N.; Sirotnak, F. M.; Smith, R. P.; Azzoli, C. G.; Gomez, J. E.; Miller, V. A.; Kris, M. G.; more...
    Cancer Chemotherapy and Pharmacology (2007)

    Fulltext@MSK | Save
  • A polyvalent vaccine for high-risk prostate patients: "Are more antigens better?"
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Fernandez, C.; Diani, M.; Jefferson, M. P.; Wilton, A.; Kelly, W. K.; Morris, M.; Solit, D.; Clausen, H.; more...
    Cancer Immunology, Immunotherapy (2007)

    Fulltext@MSK | Save
  • Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results
    Meeting Abstract

    Modi, S.; Stopeck, A.; Linden, H. M.; Sugarman, S.; Ma, W.; Solit, D.; Rosen, N.; Kersey, K.; Johnson, R. G.; Hannah, A. L.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Inhibitors of Hsp90 induce the degradation of HER2 and inhibit the growth of HER2-dependent breast tumors
    Meeting Abstract

    Solit, D. B.; Basso, A.; Smith-Jones, P.; Modi, S.; Norton, L.; Larson, S.; Neckers, L.; Scher, H.; Hudis, C.; Rosen, N.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002
    Journal Article

    Marsh, S. G. E.; Parham, P.; Dupont, B.; Geraghty, D. E.; Trowsdale, J.; Middleton, D.; Vilches, C.; Carrington, M.; Witt, C.; Guethlein, L. A.; more...
    Immunogenetics (2003)

    Fulltext@MSK | Save
  • Expression of bone morphogenetic proteins and receptors in sarcomas
    Journal Article

    Guo, W.; Gorlick, R.; Ladanyi, M.; Meyers, P. A.; Huvos, A. G.; Bertino, J. R.; Healey, J. H.
    Clinical Orthopaedics and Related Research (1999)

    Fulltext@MSK | Save